On the recordFebruary 3, 2016
It is critical, therefore, that the public can depend on approved biosimilars and that we encourage the development of new treatments.
Source
congress.govEditor's note · Context
Butterfield stresses the importance of reliable biosimilars for public health.
Share & report
More from G. K. Butterfield
Jan 13, 2022
Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and insert extraneous material into the Record on the House amendment to the Senate amendment to H.R. 5746. The…
Jan 13, 2022
Madam Speaker, I yield myself as much time as I may consume in order to close. First of all, Madam Speaker, let me thank the gentleman from Illinois (Mr. Rodney Davis) for his kind words. When Members of Congress say to each other, ``you…
Jan 13, 2022
Mr. Speaker, I would ask my friend from North Carolina to refer to the bill section that refers to voter ID. It simply says this bill sets uniform national standards for States that choose to require identification to vote. Mr. Speaker, I…
Jan 13, 2022
Madam Speaker, I say to the gentleman that I am prepared to close. Mr. Davis is my friend, and I want the world to know that. I reserve the balance of my time.
Other voices in this conversation
